Trial Profile
123I-ALTROPANE Reference Image Acquisition in Subjects With Diagnostically Uncertain Tremor (AIM)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 May 2014
Price :
$35
*
At a glance
- Drugs NAV 5001 (Primary)
- Indications Parkinson's disease; Tremor
- Focus Diagnostic use
- Sponsors Alseres Pharmaceuticals
- 18 May 2014 New trial record